Edoxaban versus Warfarin in patients with atrial fibrillation

被引：0
|
作者：
Meras Colunga, P. [1 ]
机构：
[1] Hosp Univ La Paz, Serv Cardiol, Madrid, Spain
来源：
REVISTA CLINICA ESPANOLA | 2014年 / 214卷 / 06期
关键词：
D O I：
10.1016/j.rce.2014.02.017
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：346 / 346
页数：1
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF EDOXABAN, APIXABAN, RIVAROXABAN AND DABIGATRAN VERSUS WARFARIN FOR STROKE PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
    Marchetti, M.
    Liberato, N. L.
    Rognoni, C.
    Quaglini, S.
    HAEMATOLOGICA, 2014, 99 : 487 - 487
  • [32] A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study
    Lip, Gregory Y. H.
    Merino, Jose
    Ezekowitz, Michael
    Ellenbogen, Kenneth
    Zamoryakhin, Dmitry
    Lanz, Hans
    Jin, James
    Al-Saadi, Naab
    Mercuri, Michele
    Goette, Andreas
    AMERICAN HEART JOURNAL, 2015, 169 (05) : 597 - U28
  • [33] Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study)
    Lip, Gregory Y. H.
    Merino, Jose L.
    Dan, G. Andrei
    Themistoclakis, Sakis
    Ellenbogen, Kenneth A.
    De Caterina, Raffaele
    Goudev, Assen
    Jin, James
    Melino, Michael
    Winters, Shannon M.
    Goette, Andreas
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (02): : 193 - 198
  • [34] Edoxaban for the prevention of stroke in patients with atrial fibrillation
    Escobar Cervantes, Carlos
    Luis Merino, Jose
    Barrios, Vivencio
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2019, 17 (04) : 319 - 330
  • [35] Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis
    Rognoni, Carla
    Marchetti, Monia
    Quaglini, Silvana
    Liberato, Nicola Lucio
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 39 (02) : 149 - 154
  • [36] EDOXABAN VERSUS WARFARIN IN ATRIAL FIBRILLATION ABLATION: FIRST EXPERIENCE FROM THE ENGAGE AF TIMI 48 TRIAL
    Steffel, Jan
    Ruff, Christian
    Hammershock, Rose
    Murphy, Sabina
    Lanz, Hans
    Mercuri, Michele
    Antman, Elliott
    Braunwald, Eugene
    Giugliano, Robert
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 366 - 366
  • [37] Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis
    Carla Rognoni
    Monia Marchetti
    Silvana Quaglini
    Nicola Lucio Liberato
    Journal of Thrombosis and Thrombolysis, 2015, 39 : 149 - 154
  • [38] Edoxaban versus warfarin in patients with atrial fibrillation in relation to the risk of stroke: A secondary analysis of the ENGAGE AF-TIMI 48 study
    de Groot, Joris R.
    Ruff, Christian T.
    Murphy, Sabina A.
    Hamershock, Rose A.
    Vehmeijer, Jim T.
    Ophuis, Anton J. M. Oude
    Grip, Laura
    Lanz, Hans
    Mercuri, Michele F.
    Antman, Elliott M.
    Giugliano, Robert P.
    AMERICAN HEART JOURNAL, 2021, 235 : 132 - 139
  • [39] Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 Trial
    Boriani, Giuseppe
    Ruff, Christian T.
    Kuder, Julia F.
    Shi, Minggao
    Lanz, Hans J.
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (02) : 140 - 149
  • [40] Atrial Fibrillation Edoxaban vs. Warfarin: same Effect against Stroke
    Ruchalla, Elke
    AKTUELLE KARDIOLOGIE, 2014, 3 (02) : 83 - 84
12345